These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 16956113

  • 21. Repair of myelin disease: strategies and progress in animal models.
    Duncan ID, Grever WE, Zhang SC.
    Mol Med Today; 1997 Dec; 3(12):554-61. PubMed ID: 9449127
    [Abstract] [Full Text] [Related]

  • 22. Experimental strategies to promote central nervous system remyelination in multiple sclerosis: insights gained from the Theiler's virus model system.
    Miller DJ, Asakura K, Rodriguez M.
    J Neurosci Res; 1995 Jun 15; 41(3):291-6. PubMed ID: 7563222
    [Abstract] [Full Text] [Related]

  • 23. Adult mesenchymal stem cell therapy for myelin repair in multiple sclerosis.
    Rivera FJ, Aigner L.
    Biol Res; 2012 Jun 15; 45(3):257-68. PubMed ID: 23283435
    [Abstract] [Full Text] [Related]

  • 24. Stem Cell Therapy for Multiple Sclerosis.
    Genc B, Bozan HR, Genc S, Genc K.
    Adv Exp Med Biol; 2019 Jun 15; 1084():145-174. PubMed ID: 30039439
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Remyelination in multiple sclerosis: a new role for neurotrophins?
    Althaus HH.
    Prog Brain Res; 2004 Jun 15; 146():415-32. PubMed ID: 14699977
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The cellular and molecular events of central nervous system remyelination.
    Dubois-Dalcq M, Armstrong R.
    Bioessays; 1990 Dec 15; 12(12):569-76. PubMed ID: 2080911
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Boundary cap cells are highly competitive for CNS remyelination: fast migration and efficient differentiation in PNS and CNS myelin-forming cells.
    Zujovic V, Thibaud J, Bachelin C, Vidal M, Coulpier F, Charnay P, Topilko P, Baron-Van Evercooren A.
    Stem Cells; 2010 Mar 31; 28(3):470-9. PubMed ID: 20039366
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Haplotype matching is not an essential requirement to achieve remyelination of demyelinating CNS lesions.
    Tepavcević V, Blakemore WF.
    Glia; 2006 Dec 31; 54(8):880-90. PubMed ID: 17006890
    [Abstract] [Full Text] [Related]

  • 37. The pathogenesis and basis for treatment in multiple sclerosis.
    Compston A.
    Clin Neurol Neurosurg; 2004 Jun 31; 106(3):246-8. PubMed ID: 15177777
    [Abstract] [Full Text] [Related]

  • 38. The potential use of stem cells in multiple sclerosis: an overview of the preclinical experience.
    Karussis D, Kassis I.
    Clin Neurol Neurosurg; 2008 Nov 31; 110(9):889-96. PubMed ID: 18375051
    [Abstract] [Full Text] [Related]

  • 39. Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies.
    Marro BS, Blanc CA, Loring JF, Cahalan MD, Lane TE.
    Expert Rev Neurother; 2014 Oct 31; 14(10):1169-79. PubMed ID: 25245576
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.